Pancreatic Cancer Clinical Trials
CRB-701
A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an Antibody-drug Conjugate Targeting Nectin-4, in Patients with Advanced Solid Tumors
Pfizer C3651021
A Phase 2B/3, Randomized, Double-Blind Study To Investigate The Efficacy, Safety, And Tolerability Of Ponsegromab (Pf-06946860) Compared With Placebo Both With Background First-Line Chemotherapy In Adult Participants With Cachexia And Metastatic Pancreatic Ductal Adenocarcinoma